UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States

International journal of clinical practice (Esher), 2016-09, Vol.70 (9), p.752-763

2016

Volltextzugriff (PDF)

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

PloS one, 2018-04, Vol.13 (4), p.e0195950-e0195950

2018

Volltextzugriff (PDF)

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach

PloS one, 2018-01, Vol.13 (1), p.e0191722-e0191722

2018

Volltextzugriff (PDF)

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure

PloS one, 2019-03, Vol.14 (3), p.e0213614-e0213614

2019

Volltextzugriff (PDF)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients

Stroke (1970), 2018-12, Vol.49 (12), p.2933-2944

2018

Volltextzugriff (PDF)

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

Journal of clinical medicine, 2020-05, Vol.9 (6), p.1633

2020

Volltextzugriff (PDF)

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States

Clinical and applied thrombosis/hemostasis, 2018-12, Vol.24 (9_suppl), p.261S-268S

2018

Volltextzugriff (PDF)

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study

Stroke (1970), 2018-12, Vol.49 (12), p.2933-2944

2018

Volltextzugriff (PDF)

Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis

Thrombosis and haemostasis, 2016-11, Vol.116 (5), p.975-986

2016

Volltextzugriff (PDF)

Factors associated with the occurrence of myocardial infarction in patients treated for melanoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10562-10562

2022

Volltextzugriff (PDF)

Mo1346 COLITIS DIAGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI) IN REAL-WORLD SETTINGS: TIMING OF ONSET AND PATTERNS OF CARE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1034-S-1034

2024

Volltextzugriff (PDF)

Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants

Journal of comparative effectiveness research, 2020-06, Vol.9 (9), p.603-614

2020

Volltextzugriff (PDF)

Enoxaparin Dosing After Discharge From US Hospitals in Patients With Total Knee Replacement

Clinical and applied thrombosis/hemostasis, 2012-09, Vol.18 (5), p.514-518

2012

Volltextzugriff (PDF)

REAL WORLD DISCONTINUATION RATES WITH APIXABAN VERSUS WARFARIN, DABIGATRAN, OR RIVAROXABAN AMONG ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON ANTICOAGULATION THERAPY: EARLY FINDINGS

Journal of the American College of Cardiology, 2014-04, Vol.63 (12), p.A415-A415

2014

Volltextzugriff (PDF)

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients

Thrombosis and haemostasis, 2017-06, Vol.117 (6), p.1072-1082

2017

Volltextzugriff (PDF)

Evaluation of the Risk of Atrial Fibrillation/Flutter Among Patients Initiating Ibrutinib

Blood, 2018-11, Vol.132 (Supplement 1), p.4821-4821

2018

Volltextzugriff (PDF)

Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine

Current drug safety, 2015-01, Vol.10 (2), p.152-158

2015

Volltextzugriff (PDF)

Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice

Thrombosis and haemostasis, 2018-11, Vol.118 (11), p.1951-1961

2018

Volltextzugriff (PDF)

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Journal of the American Geriatrics Society (JAGS), 2019-08, Vol.67 (8), p.1662-1671

2019

Volltextzugriff (PDF)

Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation

The American journal of managed care, 2016-01, Vol.22 (1), p.e1

2016

Volltextzugriff (PDF)

Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease

The American journal of cardiology, 2021-06, Vol.148, p.69-77

2021

Volltextzugriff (PDF)

Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease

The American journal of medicine, 2018-09, Vol.131 (9), p.1075-1085.e4

2018

Volltextzugriff (PDF)

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Mayo Clinic proceedings, 2020-05, Vol.95 (5), p.929-943

2020

Volltextzugriff (PDF)

Abstract 736: Treatment with immune checkpoint inhibitors (ICIs) and the occurrence of colitis among patients with melanoma in the United States

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.736-736

2023

Volltextzugriff (PDF)

Abstract 3367: Treatment patterns in patients with cancer-associated venous thromboembolism in the US: A real world retrospective database analysis

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3367-3367

2019

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(90)
Chinesisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study

Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis

Factors associated with the occurrence of myocardial infarction in patients treated for melanoma

Mo1346 COLITIS DIAGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI) IN REAL-WORLD SETTINGS: TIMING OF ONSET AND PATTERNS OF CARE

Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants

Enoxaparin Dosing After Discharge From US Hospitals in Patients With Total Knee Replacement

REAL WORLD DISCONTINUATION RATES WITH APIXABAN VERSUS WARFARIN, DABIGATRAN, OR RIVAROXABAN AMONG ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON ANTICOAGULATION THERAPY: EARLY FINDINGS

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice. A propensity-matched analysis of 76,940 patients

Evaluation of the Risk of Atrial Fibrillation/Flutter Among Patients Initiating Ibrutinib

Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine

Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation

Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease

Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Abstract 736: Treatment with immune checkpoint inhibitors (ICIs) and the occurrence of colitis among patients with melanoma in the United States

Abstract 3367: Treatment patterns in patients with cancer-associated venous thromboembolism in the US: A real world retrospective database analysis

Suchergebnisse filtern